Mark W Hahn Verona Pharma PLC (VRNA) insider trading activity

VRNA Quotes by TradingView

Mark W Hahn is Chief Financial Officer of Verona Pharma plc. Currently has a direct ownership of 12.4 Million shares of VRNA, which is worth approximately $1.12 Billion. The most recent transaction as insider was on Nov 01, 2022, when has been sold 454,856 shares (Ordinary Shares) at a price of $1.6 per share, resulting in proceeds of $727,769. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.4M
6.82% 3M change
16.9% 12M change
Total Value Held $1.12 Billion

Mark W Hahn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 01 2022
SELL
Payment of exercise price or tax liability
$727,769 $1.6 p/Share
454,856 Reduced 2.54%
17,458,640 Ordinary Shares
Nov 01 2022
SELL
Open market or private sale
$21,977 $1.67 p/Share
13,160 Reduced 0.08%
17,445,480 Ordinary Shares
Sep 26 2022
BUY
Grant, award, or other acquisition
-
3,600,000 Added 16.73%
17,913,496 Ordinary Shares
Aug 09 2022
SELL
Open market or private sale
$1,050,000 $1.75 p/Share
600,000 Reduced 4.02%
14,313,496 Ordinary Shares
Aug 01 2022
SELL
Open market or private sale
$9,218 $0.7 p/Share
13,168 Reduced 0.09%
14,913,496 Ordinary Shares
Aug 01 2022
SELL
Payment of exercise price or tax liability
$304,754 $0.67 p/Share
454,856 Reduced 2.96%
14,926,664 Ordinary Shares
May 03 2022
SELL
Open market or private sale
$6,256 $0.5 p/Share
12,512 Reduced 0.08%
15,381,520 Ordinary Shares
May 01 2022
SELL
Payment of exercise price or tax liability
$224,707 $0.52 p/Share
432,128 Reduced 2.73%
15,394,032 Ordinary Shares
Feb 02 2022
SELL
Open market or private sale
$7,916 $0.76 p/Share
10,416 Reduced 0.07%
15,826,160 Ordinary Shares
Feb 01 2022
SELL
Payment of exercise price or tax liability
$224,890 $0.78 p/Share
288,320 Reduced 1.79%
15,836,576 Ordinary Shares
Feb 01 2022
BUY
Grant, award, or other acquisition
$100,332 $0.75 p/Share
133,776 Added 0.82%
16,124,896 Ordinary Shares
Nov 02 2021
SELL
Open market or private sale
$6,770 $0.65 p/Share
10,416 Reduced 0.07%
15,991,120 Ordinary Shares
Nov 01 2021
SELL
Payment of exercise price or tax liability
$291,103 $0.64 p/Share
454,848 Reduced 2.76%
16,001,536 Ordinary Shares
Aug 02 2021
SELL
Open market or private sale
$8,020 $0.77 p/Share
10,416 Reduced 0.06%
16,456,384 Ordinary Shares
Aug 01 2021
SELL
Payment of exercise price or tax liability
$354,775 $0.78 p/Share
454,840 Reduced 2.69%
16,466,800 Ordinary Shares
May 03 2021
SELL
Open market or private sale
$9,062 $0.87 p/Share
10,416 Reduced 0.06%
16,921,640 Ordinary Shares
May 03 2021
SELL
Payment of exercise price or tax liability
$1,888,979 $0.89 p/Share
2,122,448 Reduced 11.14%
16,932,056 Ordinary Shares
Mar 01 2021
SELL
Open market or private sale
$30,470 $1.14 p/Share
26,728 Reduced 0.14%
19,054,504 Ordinary Shares
Jan 28 2021
BUY
Grant, award, or other acquisition
-
105,824 Added 0.55%
19,081,232 Ordinary Shares
MWH

Mark W Hahn

Chief Financial Officer
London, X0

Track Institutional and Insider Activities on VRNA

Follow Verona Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRNA shares.

Notify only if

Insider Trading

Get notified when an Verona Pharma PLC insider buys or sells VRNA shares.

Notify only if

News

Receive news related to Verona Pharma plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VRNA